Andrew Warner, MD
Emergency Medicine · Mobile, ALNPI 1538522198
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $90 and has fallen 78.5% since, to $19 in 2024.
Across 11 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$29
- Inari Medical, Inc.$19
- AstraZeneca$19
- Pacira Pharmaceuticals Incorporated$18
- CSL Behring$18
- Johnson & Johnson$17
- plus $49 from 4 others
What the payments were for
- Food & beverage$170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $29 |
| Inari Medical, Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| CSL Behring | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Novo Nordisk | 1 | $14 |
| Chiesi USA, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Genentech USA, Inc. | 1 | $11 |
How this compares
$170 in reported general payments places this provider in the 70th percentile of 565 emergency medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $694 |
| Ondansetron OdtOndansetron | 24 | $365 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $276 |
| Ibuprofen | 17 | $144 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $124 |
| Doxycycline Hyclate | 12 | $92 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $61 |
| Prednisone | 21 | $32 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Mobile
- Lisa Moreno-WaltonMobile$23K
- Jorge AlsipMobile$8K
- Richard BeverlyMobile$4K
- Edward PanacekMobile$1K
- Caroline MolinsMobile$714
- Michael SternbergMobile$681
- Paul HenningMobile$623
- Walter WhiteMobile$619
- Walker PlashMobile$611
- Mark MitchellAtmore$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.